Cointime

Kineta

company

About

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Highlights

Stock Symbol
nasdaq:KA
Total Funding Amount
$83.22M
Funding Rounds
20
Investors
10
Acquisition
1
Employee Profiles
9

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Medical Device,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active
Stock Symbol
nasdaq:KA
Legal Name
Kineta, Inc.
Also Known As
Kineta One LLC

Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold.

Kineta was founded in 2008 and is based in Seattle, Washington.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
20
$83.22M
Kineta has raised a total of $83.22M in funding over 2 rounds. Their latest funding was raised on Dec 28, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 28, 2022 Series Unknown $7.50M — — — Detail
Dec 19, 2022 IPO — — — — Detail
Jun 1, 2021 Corporate Round $17.39M 1 Cheongbo Industrial Co. (CBI) — Detail
May 5, 2020 Series Unknown $5M 1 SCHLAEPFER FAMILY FOUNDATION — Detail
Aug 6, 2019 Grant $1.80M 1 Wellcome Trust — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
5
10
Kineta is funded by 10 investors. Cheongbo Industrial Co. (CBI) and SCHLAEPFER FAMILY FOUNDATION are the most recent investors.
Investor Name Lead Investor Funding Round
Cheongbo Industrial Co. (CBI) Yes Corporate Round
SCHLAEPFER FAMILY FOUNDATION Yes Series Unknown
Wellcome Trust Yes Grant
SFC Capital Yes Series Unknown
Keiretsu Capital Yes Series B
Keiretsu Forum — Series Unknown
National Institute of Allergy and Infectious Diseases — Grant
Keiretsu Forum Northwest — Series Unknown
AngelMD — Funding Round
RJ Jones — Series Unknown

Employee Profiles

Number of Employee Profiles
9
Kineta has 9 current employee profiles, including Executive Charles Magness
Charles Magness
Executive
Craig Philips
Executive
Jacques Bouchy
Executive
Shawn Iadonato
Executive
Michael Banks
Executive
Show More

Acquisition

Kineta has acquired 1 organizations. Their most recent acquisition was Kineta (Reverse Merger With Yumanity Therapeutics) on Dec 19, 2022. They acquired Kineta (Reverse Merger With Yumanity Therapeutics) for 0.

Date Company Name
Industry Acquisition Type Price
Dec 19, 2022 Kineta (Reverse Merger With Yumanity Therapeutics)
Biotechnology merge — Detail
Cointime
Content
Company